TLR8
TLR8 (toll-like receptor 8, also known as CD288 and hTLR8) is an endosomal pattern-recognition receptor of the Toll-like receptor family. It detects microbial single-stranded RNA and signals through MYD88 to drive pro-inflammatory cytokine and interferon production. Browse Assay Genie's current range of TLR8 research reagents below, or read on for the biology behind the target.
TLR8 is an endosomal receptor with a key role in innate and adaptive immunity. It controls the host response to pathogens by recognising RNA degradation products specific to microorganisms, which are initially processed by RNASET2. It recognises GU-rich single-stranded RNA derived from SARS-CoV-2, SARS-CoV-1 and HIV-1. On binding agonists, the receptor dimerises, bringing the TIR domains of the two molecules into direct contact. This recruits the TIR-containing adapter MYD88 through homotypic interaction.
Downstream, the Myddosome signalling complex forms, involving IRAK4, IRAK1, TRAF6 and TRAF3. This activates the transcription factors NF-kappa-B and IRF7, which induce pro-inflammatory cytokines and interferons respectively. Researchers studying the TLR8 protein therefore often follow this MYD88-dependent axis as a readout of innate immune activation.
The TLR8 gene encodes a member of the Toll-like receptor family, which is highly conserved from Drosophila to humans. TLRs recognise pathogen-associated molecular patterns on infectious agents and mediate the production of cytokines needed for effective immunity. Each TLR has its own expression pattern, and TLR8 is predominantly expressed in lung and peripheral blood leukocytes. The gene lies close to another family member, TLR7, on the X chromosome. HGNC classifies it among both the CD molecules and the Toll-like receptors, which is why it also carries the name CD288. The mouse ortholog is Tlr8.
TLR8 is a pattern-recognition receptor that links detection of pathogen-derived RNA to cytokine production and the development of effective immunity.
TLR8 recognises GU-rich single-stranded RNA from SARS-CoV-2, SARS-CoV-1 and HIV-1, making it relevant to studies of viral detection.
Agonist-induced TLR8 dimerisation recruits MYD88 and builds the Myddosome with IRAK4, IRAK1, TRAF6 and TRAF3.
TLR8 signalling activates NF-kappa-B and IRF7 to induce pro-inflammatory cytokines and interferons respectively.
TLR8 is an endosomal receptor that recognises microbial single-stranded RNA, including GU-rich RNA from SARS-CoV-2, SARS-CoV-1 and HIV-1. Once activated it dimerises, recruits MYD88 and forms the Myddosome, leading to NF-kappa-B and IRF7 activation and induction of pro-inflammatory cytokines and interferons.
TLR8 is the HGNC symbol for toll like receptor 8. Aliases include CD288 and hTLR8, and the protein is named Toll-like receptor 8 in UniProt. It belongs to the Toll-like receptor family and is also classed among the CD molecules.
TLRs are highly conserved from Drosophila to humans, and TLR8 has a mouse ortholog, Tlr8. In humans the gene is predominantly expressed in lung and peripheral blood leukocytes. Check the datasheet of any product for its validated reactivity.
Other Toll-like receptors, including TLR7 which lies next to TLR8 on the X chromosome, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NR97; product specifications from Assay Genie datasheets.